[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606366":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":28,"locations":34,"responsibleParty":52,"collaborators":10,"id":54,"slug":10,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":55,"sex":61,"minAge":62,"maxAge":10,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":10,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Medtronic Vascular","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Symplicity RDN + SOC",null,"Medicare patients on a stable antihypertension medication regimen and received RDN with a Symplicity RDN system",[13],"Device: Renal Denervation (Symplicity Spyral™)",{"label":15,"type":10,"description":16,"interventionNames":10},"SOC","Medicare patients on a stable antihypertension medication regimen",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"DEVICE","Renal Denervation (Symplicity Spyral™)","Symplicity Spyral™ multi-electrode renal denervation system",[9],[24],{"name":25,"affiliation":26,"role":27},"Eric A Secemsky, MD, MSc","Beth Israel Deaconess Medical Center","PRINCIPAL_INVESTIGATOR",[29],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Kael Wherry, PhD, MS","CONTACT","612-229-0714","kael.wherry@medtronic.com",[35],{"facility":26,"status":36,"city":37,"state":38,"zip":39,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Boston","Massachusetts","02215","United States",{"type":42,"coordinates":43},"Point",[44,45],-71.05977,42.35843,{"lat":45,"lon":44},[48],{"name":49,"role":31,"phone":50,"phoneExt":10,"email":51},"Eric A. Secemsky, MD, MSc","617-632-7753","esecemsk@bidmc.harvard.edu",{"type":53,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100606366",false,"NCT07174622","Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation","Real-world Clinical Outcomes in Medicare Patients With Hypertension Treated With Symplicity Renal Denervation Plus Standard of Care Versus Standard of Care in Integrated EHR and Claims Data","SPYRAL CARE","Inclusion Criteria:\n\n* Enrolled in a Medicare plan\n* Diagnosis of uncontrolled hypertension\n* On a stable regimen of antihypertensive therapy\n\nExclusion Criteria:\n\n* A prior RDN procedure\n* Diagnosis of secondary hypertension\n* Any condition for which RDN is contraindicated","ALL","18 Years",{"count":64,"type":65},1000,"ESTIMATED","OBSERVATIONAL","This observational study will assess the long-term effectiveness of the RDN procedure for lowering blood pressure in Medicare patients with uncontrolled hypertension. This research will be conducted using de-identified electronic health records (EHR) and administrative health insurance claims data. Patients are enrolled through the submission of claims or encounter data to CMS.",[69,70,71],"Hypertension","Cardiovascular Diseases","Vascular Diseases","2026-04-21",{"date":74,"type":75},"2026-04-22","ACTUAL",{"date":77,"type":75},"2025-10-28",{"date":79,"type":65},"2029-06",{"name":5,"class":6},1]